State Release 184
Guidance for : This release provides information pertaining to the use of the Centers for Medicare & Medicaid Services� (CMS�s) drug product data to determine drug coverage by states under the Medicaid Drug Rebate (MDR) Program and also includes a comprehensive list of CMS�s resource mailboxes and their uses to ensure the questions and concerns are routed to the correct resource. Use of CMS�s Drug Product Data to Determine Drug Coverage by States Under the MDR Program CMS is aware that there are many external sources of drug product data available to stakeholders for use in determining whether a drug is a covered outpatient drug.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: October 30, 2017
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.